FDA Orange Book
Is there a generic for Impoyz?
Impoyz contains clobetasol propionate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Impoyz (clobetasol propionate). The Orange Book shows its last listed patent expires March 11, 2035.
Run it in Rivvi
Map Impoyz and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Impoyz products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| cream, topical | 0.025% | Marketed (Rx) | None | 0 | None |
NDA 209483, held by PRIMUS PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Impoyz patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10064875 | August 31, 2030 | Drug product | U-88 | 209483 |
| 10064875 | August 31, 2030 | Drug product | U-1858 | 209483 |
| 9956231 | August 31, 2030 | Drug product | U-88 | 209483 |
| 10064875 | August 31, 2030 | Drug product | U-193 | 209483 |
| 10064875 | August 31, 2030 | Drug product | U-1408 | 209483 |
| 9956231 | August 31, 2030 | Drug product | U-1408 | 209483 |
| 9956231 | August 31, 2030 | Drug product | U-193 | 209483 |
| 9956231 | August 31, 2030 | Drug product | U-742 | 209483 |
| 9956231 | August 31, 2030 | Drug product | U-1858 | 209483 |
| 10064875 | August 31, 2030 | Drug product | U-742 | 209483 |
| 11179465 | August 31, 2030 | Drug product | U-1858 | 209483 |
| 10588914 | August 31, 2030 | Drug product | U-2771 | 209483 |
| 9956231 | August 31, 2030 | Drug product | U-1761 | 209483 |
| 9855334 | March 11, 2035 | Drug product | None | 209483 |
Impoyz NDC codes
Questions
Is there a generic for Impoyz?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Impoyz (clobetasol propionate). The Orange Book shows its last listed patent expires March 11, 2035.
What is the generic name for Impoyz?
The active ingredient in Impoyz is clobetasol propionate, per the FDA Orange Book.
When does the Impoyz patent expire?
The last patent listed for Impoyz in the Orange Book expires March 11, 2035. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Impoyz and Clobetasol Propionate
- What is Clobetasol Propionate used for?FDA label uses
- Is Clobetasol Propionate a controlled substance?Federal schedule
- Generic for OluxFDA Orange Book
- Generic for Olux EFDA Orange Book
- Generic for TemovateFDA Orange Book
- Generic for Temovate EFDA Orange Book
- Generic for ClobexFDA Orange Book
- Generic for ImpekloFDA Orange Book
- Generic for ByqloviFDA Orange Book
- Corticosteroids listFDA drug class
- NDC 68040-713Impoyz NDC record